Working… Menu
Trial record 2 of 3 for:    Rocket | Fanconi Anemia

Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04069533
Recruitment Status : Recruiting
First Posted : August 27, 2019
Last Update Posted : November 1, 2019
Information provided by (Responsible Party):
Rocket Pharmaceuticals Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2023
Estimated Study Completion Date : January 2023